Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance

28 Pages Posted: 5 Feb 2010

See all articles by Mark A. Rothstein

Mark A. Rothstein

University of Louisville - Institute for Bioethics, Health Policy, and Law; University of Louisville - Louis D. Brandeis School of Law

Date Written: February 1, 2001

Abstract

The promise of new genetic research is the ability to prevent, treat, and cure a wide range of physical and mental disorders - both monogenic and complex disorders. While astonshing progress has been made in gene discovery and development of genetic tests, progress has been much slower in developing medicial interventions. Consequently, there is likely a gap of varing and indeterminante time - lasting years or even decades - between the ability to identify and predict genetic risk and the ability to prevent, treat, or cure the condition.

Keywords: privacy, confidentiality, genetics, genetic discrimination, genetic research, biobanks, pharmacogenomics, genetic information

JEL Classification: K31, K32

Suggested Citation

Rothstein, Mark A., Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance (February 1, 2001). Georgia Law Review, Vol. 35, No. 2, p. 707, 2001. Available at SSRN: https://ssrn.com/abstract=1547280

Mark A. Rothstein (Contact Author)

University of Louisville - Institute for Bioethics, Health Policy, and Law ( email )

Louisville, KY 40202
United States

HOME PAGE: http://www.louisville.edu/bioethics

University of Louisville - Louis D. Brandeis School of Law ( email )

Wilson W. Wyatt Hall
Louisville, KY 40292
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
84
Abstract Views
1,098
rank
292,447
PlumX Metrics